LY2090314
Product Specifications
CAS Number
603288-22-8
Target
GSK-3
Related Pathways
PI3K/Akt/mTOR signaling, Stem Cells
Purity
0.9991
Bioactivity
LY2090314, an effective GSK-3α/β inhibitor (IC50: 1.5 nM/0.9 nM), may improve the efficacy of platinum-based chemotherapy regimens. LY2090314 has been used in trials studying the treatment of Leukemia, Advanced Cancer, and Pancreatic Cancer.
Smiles
Fc1cc2CN(CCn3cc(C4=C(C(=O)NC4=O)c4cnc5ccccn45)c(c1)c23)C(=O)N1CCCCC1
Molecular Formula
C28H25FN6O3
Molecular Weight
512.53
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Cellubrevin Antibody [C19C14]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
244563-ML650 100 µL
CDX1 (Caudal Type Homeobox 1, MGC116915) (MaxLight 650)
Sign In for Pricing
View Details orb1084992 100 µL
Phospho-INPPL1 (Tyr986 + Tyr987) Rabbit Polyclonal Antibody (Cy7)
Sign In for Pricing
View Details EK8F117-01 48 Test
Caprine Cyclic Guanosine Monophosphate (cGMP) ELISA Kit-Sandwich
Sign In for Pricing
View Details